Halozyme Therapeutics (HALO) Tax Rate (2016 - 2026)
Halozyme Therapeutics (HALO) posted quarterly Tax Rate of 16.79% for Q1 2026, down 110.0% year-over-year from 167.91% in Q1 2025, and up 141.56% quarter-over-quarter from 40.4% in Q4 2025.
Halozyme Therapeutics (HALO) Tax Rate (2016 - 2026) Analysis & Trends
Halozyme Therapeutics (HALO) has reported Tax Rate for 11 consecutive years, with 16.79% the latest figure, recorded in Q1 2026.
- In Q1 2026, Tax Rate fell 110.0% year-over-year to 16.79%; the TTM figure through Mar 2026 stood at 30.69% (up 1093.0% YoY), while the FY2025 annual figure was 32.13%, up 1184.0% from the prior year.
- Tax Rate rose to 16.79% in Q1 2026 per HALO's latest filing, from 40.4% in the prior quarter.
- Across five years, Tax Rate topped out at 24.41% in Q2 2022 and bottomed at 40.4% in Q4 2025.
- Historically, Tax Rate has averaged 16.01% across 5 years, with a median of 19.41% in 2025.
- Annual changes were most pronounced in 2022 — Tax Rate surged 20865 bps — and 2025, when it slumped 6352 bps.
- Halozyme Therapeutics' Tax Rate stood at 18.49% in 2022, then fell by 16 bps to 15.6% in 2023, then jumped by 48 bps to 23.12% in 2024, then tumbled by 275 bps to 40.4% in 2025, then soared by 142 bps to 16.79% in 2026.
- Business Quant data shows HALO's Tax Rate at 16.79% in Q1 2026, 40.4% in Q4 2025, and 19.96% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.91% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 24.15% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -9.47% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 7.49% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -16.71% |
| 10 | Halozyme Therapeutics | 11.25 Bn | 11.02 Bn | 401.83 Mn | 19.30% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 19.30% |
| Jun 30, 2026 | 19.30% |
| Jun 30, 2026 | 19.30% |
| Mar 31, 2026 | 16.79% |
| Mar 31, 2026 | 16.79% |
| Mar 31, 2026 | 16.79% |
| Dec 31, 2025 | -40.40% |
| Dec 31, 2025 | -40.40% |
| Dec 31, 2025 | -40.40% |
| Sep 30, 2025 | 19.96% |
| Sep 30, 2025 | 19.96% |
| Sep 30, 2025 | 19.96% |
| Jun 30, 2025 | 19.41% |
| Jun 30, 2025 | 19.41% |
| Jun 30, 2025 | 19.41% |
| Mar 31, 2025 | 17.89% |
| Mar 31, 2025 | 17.89% |
| Mar 31, 2025 | 17.89% |
| Dec 31, 2024 | 23.12% |
| Dec 31, 2024 | 23.12% |